Scientists launch registry to unlock secrets of rare lung cancer
NCT ID NCT04881916
First seen Apr 04, 2026 · Last updated May 24, 2026 · Updated 10 times
Summary
This study aims to gather medical history and tissue or saliva samples from 100 people with a specific type of lung cancer called ALK+ non-small cell lung cancer. The goal is to create a registry that helps researchers understand the immune and genetic features of this cancer. Participants must be 18 or older and have advanced disease that cannot be treated with surgery or radiation.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for NON-SMALL CELL LUNG CANCER are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Massachusetts General Hospital Cancer Center
Boston, Massachusetts, 02114, United States
Conditions
Explore the condition pages connected to this study.